Skip to content

Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study

Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With Allergic Rhinitis. RinASol- Pilot Study (Allergic Rhinitis Solution)

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02729012
Acronym
RinASol
Enrollment
30
Registered
2016-04-06
Start date
2015-10-31
Completion date
2016-06-30
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Keywords

Children

Brief summary

The main objective of RinASol project is to assess in patients with seasonal Allergic Rhinitis the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on nasal inflammation by means of nasal cytology. The secondary objective is the symptom score assessment by T5SS Questionnaire (Total Symptom Score 5)

Interventions

DRUGhypertonic saline solution (NACL 3%+NAHCO3)

Treatment with nebulized hypertonic saline solution (NACL 3%+NAHCO3)

Treatment with nebulized Saline Solution (NACL 0,9%)

Sponsors

Stefania La Grutta, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* Clinical history of Allergic Rhinitis (for at least 1 year) * 6 years old ≤ children age ≤ 14 years old * Total Symptom Score 5: \>5 in the last 4 days before screening.

Exclusion criteria

* Signs of acute infections of upper and lower respiratory tract. * Metabolic, immunological, systemic diseases * Respiratory tract deformity * Systemic/Topical therapies with antibiotics or corticosteroids in the previous 30 days. * Active smoker.

Design outcomes

Primary

MeasureTime frameDescription
Symptom score assessment28 daysThe main objective is to evaluate the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on the symptom score assessed by T5SS Questionnaire (Total Symptom Score 5)

Secondary

MeasureTime frameDescription
Nasal cytology pattern28 daysThe secondary objective is to evaluate the effect of hypertonic saline solution NACL 3%+NAHCO3 vs the effect of standard saline solution on nasal inflammation, in patients with seasonal Allergic Rhinitis, by means of nasal cytology.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026